Search our Database of Scientific Publications and Authors

I’m looking for a
    Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy.
    Br J Urol 1998 Dec;82(6):835-41
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
    Objective: To evaluate our experience with primary carcinomas of the female urethra, by analysing the impact of tumour variables and treatment on overall, disease-specific, local recurrence- and metastasis-free survival.

    Patients And Methods: Between 1958 and 1994, 72 women (median age 60 years, mean 59, range 21-84) with primary urethral carcinoma were identified. They were followed for a median (range) of 85 (0-384) months. The patients were stratified by stage, nodal status, histology, treatment, type of surgery, site of disease, year of diagnosis and smoking habit.

    Results: In a univariate analysis, stage, nodal status, type of surgery and site of the disease were important factors for survival and recurrence. In a multivariate analysis, primary stage, nodal status and site of disease were independent predictors of survival.

    Conclusion: Current modalities of treatment are ineffective for local control and survival; new treatment strategies are needed for female urethral cancers.

    Similar Publications

    Male urethral carcinoma: analysis of treatment outcome.
    Urology 1999 Jun;53(6):1126-32
    Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
    Objectives: To evaluate our experience with primary carcinomas of the male urethra and to analyze the impact of tumor variables and treatment on overall, disease-specific, local recurrence-free, and metastasis-free survival.

    Methods: Between 1958 and 1996, we identified 46 men with primary carcinoma of the bulbar and anterior urethra. The median follow-up was 125 months (1 to 336). Read More
    Long-term outcome of combined modality therapy in retroperitoneal and deep-trunk soft-tissue sarcoma: analysis of prognostic factors.
    Int J Radiat Oncol Biol Phys 2002 Oct;54(2):514-9
    Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
    Purpose: To evaluate the long-term outcome of surgery and postoperative radiotherapy (RT) in retroperitoneal and deep-trunk soft-tissue sarcoma, and to identify the prognostic factors for local control, disease-free survival, and overall survival.

    Methods And Materials: Between January 1980 and December 1998, 60 patients with nonmetastatic retroperitoneal and deep-trunk soft-tissue sarcoma were treated at Wayne State University using combined surgery and RT. The location was retroperitoneal in 38 patients (63%) and deep trunk in 22 (27%). Read More
    Surgical treatment for local control of female urethral carcinoma.
    Urol Oncol 2004 Sep-Oct;22(5):404-9
    Department of Urology, Mayo Clinic, Rochester, MN, USA.
    We reviewed 53 patients (mean age 63 years) who underwent partial urethrectomy (n = 26) or radical extirpation (n = 27) for primary female urethral cancer from 1948 through 1999. Clinical stage, histology, high pathologic stage (3 or 4) and grade, tumor location, nodal status, surgery type, adjuvant therapy, and treatment decade were candidate outcome predictors. The predominant carcinomas were squamous cell (n = 21), transitional cell (TCC) (n = 15), and adenocarcinoma (n = 14). Read More
    Clinicopathological presentation of tongue cancers and early cancer treatment.
    J Coll Physicians Surg Pak 2006 Mar;16(3):179-82
    Department of Otolaryngology and Head and Neck Surgery, Pakistan Institute of Medical Sciences, Islamabad (PIMS).
    Objective: To analyze clinicopathological presentation of tongue cancers and to calculate survival rates (SR) with disease free survival rates (DFSR) and recurrence rates (RR) in different treatment modalities and to compare the results of surgery alone and radiotherapy alone in stage I and stage II disease and to calculate better option of treatment in early tongue cancers.

    Design: A longitudinal study.

    Place And Duration Of Study: Department of Otolaryngology and Head and Neck Surgery, Pakistan Institute of Medical Sciences, Islamabad (PIMS) from January 1987 to June 1998. Read More